BXI.TO Key Stats
|Revenue (Quarterly YoY Growth)||-55.46%|
|EPS Diluted (TTM)||-0.2881|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-61.47M|
|Gross Profit Margin (Quarterly)||-78.86%|
|Profit Margin (Quarterly)||-13998%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM) Pro||Go Pro|
BXI.TO Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Bioexx Specialty Proteins is down 88.89% over the last year vs S&P 500 Total Return up 30.43%, and Portage Biotech up N/A.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
You may also be interested in these BXI.TO related companies
Pro Ratings for BXI.TO
Pro Strategies Featuring BXI.TO
Did Bioexx Specialty Proteins make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Bioexx Specialty Proteins, Inc. is involved in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials.